Chapter 1. Research Framework
1.1 Research Objective
1.2 Product Overview
1.3 Market Segmentation

Chapter 2. Research Methodology
2.1 Qualitative Research
2.1.1 Primary & Secondary Sources
2.2 Quantitative Research
2.2.1 Primary & Secondary Sources
2.3 Breakdown of Primary Research Respondents, By Region
2.4 Assumption for the Study
2.5 Market Size Estimation
2.6. Data Triangulation

Chapter 3. Executive Summary: Global Pharma & Biotech CRM Software Market

Chapter 4. Pharma & Biotech CRM Software Market
4.1. Industry Value Chain Analysis
4.1.1. Developer
4.1.2. Technology Integrator
4.1.3. Service Provider
4.1.4. End User
4.2. Consumer Buying Behavior for CRM (by Modules/Functions)
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of Substitutes
4.3.4. Threat of New Entrants
4.3.5. Degree of Competition
4.4. Market Dynamics and Trends
4.4.1. Growth Drivers
4.4.2. Restraints
4.4.3. Challenges
4.4.4. Key Trends
4.5. Competition Dashboard
4.5.1. Market Concentration Rate
4.5.2. Company Market Share Analysis (Value %), 2020
4.5.3. Competitor Mapping
4.6. Market Outlook, by Revenue (US$ Mn)
4.6.1. Pricing Model Analysis (US$)
4.6.2. Market Size & Forecast, 2016-2027
4.6.3. Opportunity Share (2020-2027)
4.7. Impact Assessment of Coivd-19

Chapter 5. Pharma & Biotech CRM Software Market Analysis, By Deployment
5.1. Market Size and Forecast, 2016-2027 (US$ Mn)
5.1.1. On-Premises
5.1.2. Cloud (SaaS)

Chapter 6. Pharma & Biotech CRM Software Market Analysis, By Enterprise Size
6.1. Market Size and Forecast, 2016-2027 (US$ Mn)
6.1.1. Large Enterprises
6.1.2. Full and Medium Enterprises

Chapter 7. Pharma & Biotech CRM Software Market Analysis, By Industry
7.1. Market Size and Forecast, 2016-2027 (US$ Mn)
7.1.1. Pharmaceutical
7.1.2. Biotech

Chapter 8. Pharma & Biotech CRM Software Market Analysis, By Technology
8.1. Market Size and Forecast, 2016-2027 (US$ Mn)
8.1.1. AI CRM
8.1.2. Conventional CRM

Chapter 9. Pharma & Biotech CRM Software Market Analysis, By Region
9.1. Market Size and Forecast, 2017 - 2030 (US$ Mn)
9.1.1. Americas
9.1.1.1. North America
9.1.1.2. South America
9.1.2. Europe
9.1.2.1. UK
9.1.2.2. Germany
9.1.2.3. France
9.1.3. Asia Pacific
9.1.3.1. China
9.1.3.2. India
9.1.3.3. Japan
9.1.4. Latin America
9.1.4.1. Brazil
9.1.4.2. Mexico
9.1.5. Middle East & Africa

Chapter 10. Americas Pharma & Biotech CRM Software Market Analysis
10.1. Key Insights
10.2. Regional Snapshot
10.3. Market Size and Forecast, 2016-2027 (US$ Mn)
10.3.1. By Deployment
10.3.2. By Enterprise Size
10.3.3. By Industry
10.3.4. By Technology
10.3.5. By Country

Chapter 11. Europe Pharma & Biotech CRM Software Market Analysis
11.1. Key Insights
11.2. Regional Snapshot
11.3. Market Size and Forecast, 2016-2027 (US$ Mn)
11.3.1. By Deployment
11.3.2. By Enterprise Size
11.3.3. By Industry
11.3.4. By Technology
11.3.5. By Country

Chapter 12. APAC Pharma & Biotech CRM Software Market Analysis
12.1. Key Insights
12.2. Regional Snapshot
12.3. Market Size and Forecast, 2016-2027 (US$ Mn)
12.3.1. By Deployment
12.3.2. By Enterprise Size
12.3.3. By Industry
12.3.4. By Technology
12.3.5. By Country

Chapter 13. Middle East & Africa Pharma & Biotech CRM Software Market Analysis
13.1. Key Insights
13.2. Regional Snapshot
13.3. Market Size and Forecast, 2016-2027 (US$ Mn)
13.3.1. By Deployment
13.3.2. By Enterprise Size
13.3.3. By Industry
13.3.4. By Technology
13.3.5. By Country

Chapter 14. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
14.1. Oracle Corporation
14.2. QuintilesIMS (IQVIA)
14.3. Veeva Systems
14.4. Salesforce
14.5. Aurea
14.6. bpm'online
14.7. Euris
14.8. Indegene
14.9. Infonis International
14.10. Interactive Medica
14.11. Media-soft Inc.
14.12. Navicon
14.13. Synergistix
14.14. TrueBlue
14.15. Pitcher Inc.
14.16. Prolifiq
14.17. StayinFront
14.18. Cirrius
14.19. Aktana
14.20. IBM Watson